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ABSTRACT Tacrine (1,2,3,4-tetrahydro-9-acridinamine monohydrate) is an inhibitor of acetylcholinesterase currently used
in the treatment of the symptoms of Alzheimer's disease. The present study demonstrates preferential binding of this drug
to acidic phospholipids, as revealed by fluorescence polarization, penetration into lipid monolayers, and effects on the
thermal phase behavior of dimyristoyl phosphatidic acid (DMPA). A fivefold enhancement in the polarization of tacrine
emission is evident above the main phase transition temperature (Tm) of DMPA vesicles, whereas below Tm only a 0.75-fold
increase is observed. In contrast, the binding of tacrine to another acidic phospholipid, dimyristoylphosphatidylglycerol, did
not exhibit strong dependence on Tm. In accordance with the electrostatic nature of the membrane association of tacrine, the
extent of binding was augmented with increasing contents of egg PG in phosphatidylcholine liposomes. Furthermore, [NaCI]
> 50 mM dissociates tacrine (albeit incompletely) from the liposomes composed of acidic phospholipids. Inclusion of the
cationic amphiphile sphingosine in egg PG vesicles decreased the membrane association of tacrine until at 1:1 sphingosine:
egg PG stoichiometry binding was no longer evident. Tacrine also penetrated into egg PG but not into egg PC monolayers.
Together with broadening of the main transition and causing a shoulder on its high temperature side, the binding of tacrine
to DMPA liposomes results in a concentration-dependent reduction both in the combined enthalpy AH of the above
overlapping endotherms and the main transition temperature Tm. Interestingly, these changes in the thermal phase behavior
of DMPA as a function of the content of the drug in vesicles were strongly nonlinear. More specifically, upon increasing
[tacrine], Tm exhibited stepwise decrements. Simultaneously, sharp minima in AH were observed at drug:lipid stoichiometries
of approximately 2:100 and 25:100, whereas a sharp maximum in AH was evident at 18:100. The above results are in keeping
with tacrine causing phase separation processes in the bilayer and may also relate to microscopic drug-induced ordering
processes within the membrane.
INTRODUCTION
Alzheimer's disease is a major cause of progressive demen-
tia in aging populations. Histologically, this disease is char-
acterized by intracerebral amyloid fibril deposition, which
has been identified to be amyloid (3-protein, a proteolytic
cleavage product of amyloid (3-precursor protein (APP)
(Sisodia and Price, 1995). Defective proteolysis of APP
produces hydrophobic peptides 39 to 43 amino acid residues
long, with a strong tendency to form aggregates (Soreghan
et al., 1994). A(3-Peptides bind to liposomes composed of
acidic phospholipids, and their binding is driven by electro-
static attraction combined with a weak hydrophobic force
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(Terzi et al., 1994). Furthermore, this interaction facilitates
the (3-sheet formation by synthetic A,B-peptides (Terzi et al.,
1994). There are reports indicating that the membrane bind-
ing of A,B may have a role in the pathogenesis of Alzhei-
mer's disease (Yanagisawa et al., 1995). The only drug
approved for the treatment of Alzheimer's disease is tacrine
(Fig. 1). Its promising therapeutic efficiency has been at-
tributed to the inhibition of acetylcholinesterase (Adem,
1992). However, recent studies have shown that the acetyl-
cholinesterase-inhibiting efficiency of tacrine is rather poor,
thus suggesting that it may exert its beneficial effects by
other mechanism(s) (Adem, 1992; Xiao et al., 1993;
Dell'Antone et al., 1995).
A large number of drugs possess as a common structural
motif-a hydrophobic aromatic ring system, together with a
short side chain containing a protonating amino group
(Hanpft and Mohr, 1985). This class of compounds binds to
phospholipids and in membranes probably interacts with
their negatively charged phosphate groups, whereas the
aromatic moiety resides either in the interfacial region (Tsai
et al., 1987) or deeper within the membrane, the exact
localization depending on the distance between phenyl rings
and the amino group (Young et al., 1992). Several local and
general anesthetics such as lidocaine (Barthel et al., 1988)
and dibucaine (Seelig et al., 1988; Seelig and Ganz, 1991),
as well as various neuroleptics, e.g., chlorpromazine (Lieber
et al., 1984; Luxnat and Galla, 1986) and (3-blockers such as
propranolol (Herbette et al., 1983; Cao et al., 1991; Rhodes
et al., 1992) can be allocated to this category. Likewise,
amlodipine, a calcium channel blocker, resides in the inter-
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FIGURE 1 The chemical structure of tacrine.
facial region of phosphatidylcholine membranes and inter-
acts with the lipid phosphate (Bauerle and Seelig, 1991).
One of the pharmacologically active compounds best char-
acterized with respect to its lipid interactions is adriamycin,
a widely used cytotoxic drug that binds to acidic phospho-
lipids with a high affinity (e.g., Goormaghtigh and Ruyss-
chaert, 1984; Mustonen and Kinnunen, 1991, 1993; Mus-
tonen et al., 1993). It has been postulated to reside in two
distinct binding sites in membranes: a superficial site and a
site involving drug penetration into the hydrocarbon region
of the membrane (Henry et al., 1985). Because of its chem-
ical structure, i.e., a protonating amino group directly at-
tached to an aromatic ringsystem (Fig. 1), tacrine should
also favor partitioning into lipid bilayers. Accordingly, we
investigated the interactions of this drug with phospholipids
using fluorescence polarization and penetration into lipid
monolayers, and studied by DSC its influence on phospho-
lipid thermal phase behavior.
MATERIALS AND METHODS
Materials
HEPES, EDTA, DOPC, DMPC, plant PI, DOPA, egg PE, and porcine
pancreatic PLA2 were from Sigma, and egg PG, brain PS, and DMPA were
from Avanti Polar Lipids (Alabaster, AL). DMPG was from Alexis
(Laufelfingen, Switzerland). D-Sphingosine was purchased from Matreya
(Pleasant Gap, PA). Tacrine was a generous gift from Parke-Davis Phar-
maceuticals (Chicago, IL). PPHPG was from K&V Bioware (Espoo, Fin-
land). The purity of lipids was checked by thin-layer chromatography on
silicic acid-coated plates (Merck, Darmstadt, Germany) using a chloro-
form/methanol/water (65:25:4, v/v/v) solvent system. The concentrations
of the phospholipids were determined by phosphorus assay (Bartlett, 1959)
and those of cholesterol, sphingosine, and tacrine by dry weight.
Fluorescence polarization measurements were carried out with an SLM
4800S spectrofluorometer equipped with Glan-Thompson calcite prism
polarizers. Excitation at 330 nm and emission at 370 nm were selected with
monochromators. Bandwidths of 1 and 16 nm were used for the excitation
and emission beams, respectively. Emission was also monitored with a
long-pass filter (350-410 nm). At the lipid:tacrine ratios used the addition
of the drug did not cause changes in the absorbance of the samples. Values
of steady-state fluorescence polarization P were calculated by the follow-
ing equation (Lakowicz, 1983):
II - 11
II+ L1
Differential scanning calorimetry
MLVs were prepared by mixing the appropriate amounts of the lipid in
chloroform and tacrine in methanol. The drug-lipid mixtures were then
evaporated to dryness under a stream of nitrogen, and traces of solvent
were subsequently removed by evacuation under reduced pressure for at
least 2 h. The dry residues were hydrated above the main transition
temperature of the lipid components with 5 mM HEPES buffer (pH 7.4)
containing 0.1 mM EDTA. The lipid concentration was 0.7 mM. The
samples were then maintained on ice overnight before the heat capacity
scans were recorded with a high-sensitivity adiabatic differential scanning
calorimeter (DASM-4; Biopribor, Puschino, Russia) at a heating rate of
0.5°C/min. All samples had the same thermal history. Transition enthalpies
are expressed in kilojoules per mole of phospholipid and were determined
by integration of the peaks, using the internal electrical power calibration
signal as a reference. The calorimeter was connected to a 486 PC via a
DTO1-EZ data acquisition board (Data Translation, Marlboro, MA), and
data were analyzed and deconvoluted using the routines of Origin Software
(Microcal, Northampton, MA). The enthalpy values given refer to the total
enthalpy content of the main transition and the tacrine-induced shoulder.
Deviation of the heat capacity from the baseline was taken as the beginning
of the transition. Likewise, the point where the enthalpy returned back to
the baseline was taken as the end of the transition. The deconvolution
procedure used rests on the assumption that the observed enthotherms can
be approximated as a linear combination of multiple, independent two-state
transitions (Mabrey et al., 1978).
Monolayer experiments
Penetration of tacrine into egg PG monolayers was monitored using mag-
netically stirred circular wells (surface area, 31 cm2; volume, 50 ml) drilled
in Teflon. Surface pressure was monitored with a platinum Wilhelmy plate
attached to a microbalance. Aqueous subphase was 5 mM HEPES con-
taining 0.1 mM EDTA (pH 7.4). The lipid was spread on the air-buffer
interface from a chloroform solution. All experiments were performed at
ambient temperature (-240C). The lipid monolayer was allowed to stabi-
lize for 15 min before the injection of tacrine into the subphase. The output
from the microbalance was connected to a 486 PC computer via a
DTO1-EZ data acquisition board, and data were analyzed by Origin
Software.
Fluorescence measurements
For fluorescence polarization studies liposomes were prepared as follows.
After mixing of the desired lipid compositions in chloroform the solvent
was removed under a stream of nitrogen. The dry residues were then
maintained under reduced pressure overnight and subsequently hydrated in
5 mM HEPES, 0.1 mM EDTA (pH 7.4) at least 10°C above the gel --
liquid crystalline transition temperature (Tm) of the phospholipid in ques-
tion. To obtain large unilamellar vesicles (LUVs) the dispersions were
extruded through Millipore (Bedford, MA) 0.1-,um pore size polycarbonate
filters (at a lipid concentration of 1.5 ,umol/500 j,l) using a LiposoFast
low-pressure homogenizer (Avestin, Ottawa, Canada) essentially as de-
scribed (Olson et al., 1979; MacDonald et al., 1991).
Assay for phospholipase A2
Phospholipase A2 activity was determined by the kinetic assay described
previously (Thuren et al., 1985). Liposomes were formed by rapidly
injecting an ethanol solution of PPHPG (68 ,ul 1.184 mM) into the buffer
(1.6 ml) to yield a lipid concentration of 50 pM. Of this solution, 100-,ul
aliquots were pipetted into 2 ml of 5 mM HEPES buffer (pH 7.4) to obtain
a final lipid concentration of 2.5 pM in the reaction mixture. The reactions
were started by the addition of 50 ng of PLA2, whereafter the progress of
the phospholipid hydrolysis was followed by measuring pyrene monomer
intensity at 400 nm using a Perkin-Elmer LS50 spectrofluorometer with a
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magnetically stirred, thermostated cuvette compartment. The excitation
wavelength was 344 nm, and the excitation and emission bandwidths were
5 nm. The assay was calibrated by adding known picomolar aliquots of
(pyren- 1-yl)hexanoate to the reaction mixture in the absence of the enzyme
while detecting pyrene monomer emission.
RESULTS
Binding of tacrine to LUVs
Tacrine is intensively fluorescent, with excitation and emis-
sion maxima at 330 nm and 375 nm, respectively (Fig. 2).
This allows its binding to liposomes to be monitored by
following the increase in its emission polarization, P. Ex-
periments were conducted by adding increasing concentra-
tions of LUVs (up to a final concentration of 120 ,uM) to a
3.9 ,uM tacrine solution so as to increase the lipid:drug ratio.
Association of the drug with acidic phospholipids results in
a significant increase in P (Fig. 3). For LUVs composed of
plant PI or egg PG, at a 1:30 drug:lipid molar ratio P
increases ninefold, from 0.025 to 0.225. When the different
lipids were compared, the values for P increased in the
sequence DOPA < brain PS < egg PG < plant PI, whereas
no change in emission anisotropy was seen for DOPC
LUVs, indicating a lack of interaction with the latter lipid.
As egg PE does not form bilayers at neutral pH, it was
included in a DOPC matrix in increasing molar ratios (up to
75 mol%). However, as in the case of DOPC, no evidence
for the association of tacrine with egg PE-DOPC mixtures
was observed (data not shown). Likewise, the inclusion of
increasing concentrations of palmitic acid (up to 75 mol%)
in DOPC liposomes did not result in the membrane associ-
ation of tacrine (data not shown).
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FIGURE 3 Increase in the fluorescence polarization of 3.9 ,uM tacrine
due to increasing amounts of LUVs composed of plant PI (A), brain PS
(V), egg PG (0), DOPA (*), or DOPC (U). The medium was 5 mM
HEPES, 0.1 mM EDTA (pH 7.4), and the temperature was 25°C.
Influence of NaCI and pH
Increasing ionic strength dissociates electrostatically mem-
brane-bound molecules. As depicted in Fig. 4, 100 mM
NaCl partly dissociates tacrine from vesicles composed of
acidic phospholipids, and at 1:7.7 drug:lipid molar ratio a
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FIGURE 2 Fluorescence excitation (left) and emission (right) spectrum
of 3.9 ,uM tacrine in 5 mM HEPES, 0.1 mM EDTA (pH 7.4). The
temperature was 25°C.
p
[NaCI], mM
FIGURE 4 Reduction in fluorescence polarization upon increasing
[NaClI]. The liposomes were prepared from egg PG (0) and plant PI (A).
Otherwise the conditions were as described in the legend for Fig. 3.
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decrease from 0.123 to 0.059 in fluorescence polarization is
seen. At higher salt concentrations (up to 250 mM) no
further decrease in binding occurs. Changes in [H+] also
influence the membrane binding of tacrine (Fig. 5). Low-
ering pH increases the protonation of egg PG, and the
surface charge of liposomes is decreased. At pH 4.0 binding
of tacrine to liposomes is diminished, whereas increasing
the pH to 7.4 results in a twofold increase in fluorescence
polarization, from 0.063 to 0.121. Inclusion of 150 mM
NaCl decreases the membrane association of tacrine, and
between pH 4 and pH 7.4 only a 1.5-fold increase is seen in
P, from 0.039 to 0.060. Results similar to those above were
obtained when brain PS was used instead of egg PG (data
not shown).
Effect of surface charge
To vary the negative surface charge density of DOPC
LUVs, increasing amounts of egg PG were included. This is
accompanied by an increase in the binding of the drug to
liposomes, as revealed by the enhanced fluorescence polar-
ization (Fig. 6 A). Compared to DOPC LUVs, and at a
drug:lipid molar ratio of 1:7.7, tacrine polarization increases
fivefold (to 0.14) upon association of this drug with DOPC:
egg PG (1:7.7 molar ratio) LUVs. Under the same condi-
tions as above, the inclusion of 150 mM NaCl results in a
decrease in the membrane association of tacrine, and only a
twofold increase in P was observed. To determine whether
the glycero-phospholipid structure is essential for the mem-
brane binding of tacrine, cholesteryl sulfate was utilized as
the negatively charged lipid. Notably, for DOPC vesicles
containing 50 mol% cholesteryl sulfate, the fluorescence
polarization of tacrine increased to 0.155, in keeping with
the membrane association of the drug (data not shown).
To neutralize the negative charge of egg PG, increasing
amounts of the positively charged single-chain amphiphile
sphingosine were included in LUVs. We have previously
shown that Sph prevents the mainly electrostatic membrane
association of cytochrome c and adriamycin (Mustonen et
al., 1993). A similar observation was now made for the
membrane association of tacrine. Addition of Sph to egg PG
vesicles caused a gradual decrease in the membrane binding
of tacrine, and at 1:1 egg PG:Sph ratio no binding was
evident (Fig. 6 B).
Effects of the phospholipid phase state
and cholesterol
Below the Tm ofDMPA at 30°C an increase in fluorescence
polarization of tacrine from 0.020 only to 0.035 was mea-
sured, whereas at 60°C (9.3°C above the Tm of DMPA)
values for P increased fivefold (to 0.10) upon the membrane
association of the drug (Fig. 7). This is compatible with the
notion that increasing lipid surface density leads to solute
exclusion (de Young and Dill, 1988). Reduced binding of
several local anesthetics to DMPA membranes below Tm
p v,vu.
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FIGURE 5 Influence of pH on the binding of tacrine to egg PG LUVs.
Concentration of the drug was 3.9 ,uM and that of phospholipid 30 ,uM,
corresponding to a drug:lipid ratio of 1:7.7. Binding was measured in both
the presence (-) and absence (U) of 150 mM [NaCI]. Otherwise the
conditions were as described in the legend for Fig. 3.
has been reported (Kaminoh et al., 1989). Interestingly, in
contrast to DMPA, for DMPG the maximum value of P of
tacrine polarization is 0.13 at both 10°C and 35°C, i.e.,
below and above the Tm of this phospholipid at 24°C.
Tacrine did not bind to DMPC, either below (at 10°C) or
above (at 30°C) its Tm at 24°C (data not shown). Cholesterol
is a major constituent of cellular membranes and has pro-
found effects on their physical properties. It has been shown
to influence the membrane binding of several drugs (Auger
et al., 1988). Accordingly, it was therefore of interest to
study its effects on the membrane binding of tacrine. Inter-
estingly, LUVs with increasing cholesterol:egg PG molar
ratios did not differ from DOPC:egg PG vesicles in their
binding of tacrine (data not shown).
Monolayer measurements
As a complementary technique allowing further insight to
the binding of tacrine to phospholipids, we studied the
association of this drug with monomolecular films residing
on an air-water interface. The addition of tacrine to the
subphase produced a rapid increase in the surface pressure
(Awr) of egg PG monolayers (Fig. 8 A). Instead, no pene-
tration of this drug into egg PC films was observed, even at
low lipid packing densities, thus concealing the lack of
interaction. In the range of surface pressures between 5 and
30 mNNm-1, the increase in the surface pressure due to
tacrine penetration exhibited a maximum at approximately
15 mNm-1; at higher surface pressures the penetration
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FIGURE 6 (A) The effect of increasing egg PG content in egg PC
liposomes on the membrane association of tacrine, as measured by the
increase in its fluorescence polarization. Binding was measured in both the
presence (-) and absence (-) of 150 mM [NaCl]. (B) Reversal of mem-
brane association of tacrine by increasing amounts of sphingosine included
in egg PG LUVs. Tacrine and lipid concentrations were held constant at 3.9
,uM and 120 ,uM, respectively.
appears to be hindered because of enhanced lateral packing
of phospholipids (Fig. 8 B). Monolayer experiments thus
support the notion of an electrostatic interaction of tacrine
with acidic phospholipids, to be followed by penetration of
the drug into the bilayer. In addition, these experiments
clearly demonstrate that precipitation of the drug in the
aqueous phase is unlikely under the conditions employed.
p
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FIGURE 7 Influence of the phase state of DMPA on the membrane
association of tacrine. The binding was measured both above (at 60°C, *)
and below (at 30°C, *) the Tm of DMPA. Otherwise the conditions were
as described in the legend for Fig. 3.
DSC measurements
The above data clearly show a strong binding of tacrine to
acidic phospholipids. Accordingly, it was of interest to
study the consequences of the drug-lipid interaction for the
thermal phase behavior of the phospholipid membranes, as
revealed by differential scanning calorimetry. Our data re-
veal the main transition of neat DMPA to be best fitted with
a combination of three overlapping enthalpy peaks obeying
Gaussian distribution (Fig. 9 A). Increasing concentrations
of tacrine caused a nonlinear decrease in the main phase
transition temperature Tm of DMPA (Fig. 9 B). A decrease
in the transition enthalpy was accompanied by an increase
in the half-width of the peak, in keeping with reduced
cooperativity. In the presence of tacrine a shoulder on the
high temperature side of the main transition peak becomes
evident, thus suggesting that phase separation takes place
(Fig. 9 C). This shoulder becomes more clearly evident at
tacrine concentrations exceeding 19 mol%. Deconvolution
of the peak suggests that its enthalpy content increases from
0.5 to 3.5 kJ/mol as the content of tacrine is increased from
24 to 40 mol%, respectively. The drug-induced shoulder
represents a maximum of 16% of the total enthalpy AH. At
drug:lipid ratios exceeding 1:4 a new transition at 35.2°C
with an enthalpy of 1.2 kJ/mol was observed. The enthalpy
of this transition increased and its temperature decreased
linearly with increasing tacrine:DMPA molar ratio, and at
1:2 the transition was observed at 34.2°C with an enthalpy
of 4.7 kJ/mol. In keeping with our fluorescence polarization
data, increasing concentrations of tacrine up to 1:2 drug:
lipid molar ratio did not influence the phase behavior of
DMPC MLVs (data not shown).
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FIGURE 8 (A) Time course of the increase in surface pressure induced
by the addition of 1 ,tM tacrine (arrow) to the buffer underneath either an
egg PG (upper trace) or an egg PC (lower trace) monolayer initially at 13.8
and 13.5 mN m-l. The magnetically stirred aqueous subphase was 5 mM
HEPES, 0.1 mM EDTA (pH 7.4). (B) Increase in the surface pressure (Air)
of egg PG monolayers due to the addition of 1 ,LM tacrine to the subphase,
plotted as a function of the initial pressure nT.
Compilation of the data obtained by DSC is shown in
Fig. 10. Interestingly, in the presence of increasing con-
tents of tacrine a strongly irregular variation both in Tm
as well as in the combined enthalpy of the main transition
and the drug-induced shoulder was evident. With increas-
ing [tacrine] Tm exhibited stepwise decrements at approx-
imately 15:100, 30:100, and 42:100 drug:lipid molar
ratios (Fig. 10 A). Simultaneously, sharp minima in AH
were observed at drug:lipid stoichiometries of approxi-
mately 2:100 and 25:100, the enthalpy finally plateauing
.5
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FIGURE 9 (A) Deconvolution of the main transition of neat DMPA by
a combination of three overlapping Gaussian enthalpy peaks. (B) DSC
thermograms for 0.7 mM DMPA in 20 mM HEPES (pH 7.4) containing 0.1
mM EDTA in the absence (a) and in the presence of 11.5 (b), 19.5 (c), 32
(d), and 45 (e) mol% of tacrine. (C) Deconvolution of the main transition
of DMPA containing 28.5 mol% tacrine, using the same method as de-
scribed for A.
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FIGURE 10 (A) The dependence of the main transition temperature Tm
of DMPA on the concentration of tacrine. Arrows indicate the Tm steps at
distinct tacrine:DMPA molar ratios. Lipid concentration was maintained
constant at 0.7 mM in 20mM HEPES (pH 7.4) containing 0.1 mM EDTA.
All samples had the same thernal history. (B) Influence of increasing
concentrations of tacrine on the total enthalpy AH of DMPA.
between 37:100 and 1:2. A sharp maximum in AH was
evident at 18:100, together with less distinguished peaks
at about 3:100, 26:100, and 32:100 (Fig. 10 B). To
determine the standard error of enthalpy, measurements
of 0, 13, 25, 27, 30, and 40 mol% of tacrine were studied.
The standard deviation calculated from five separate
DSC runs for each sample varied between 1.7% and
5.6%, and was -1% for neat DMPA. Accordingly, the
enthalpy changes shown cannot be explained by a large
experimental variation.
Influence of tacrine on PLA2 activity
The chemical structure of tacrine resembles those of chlor-
promazine and lidocaine, which are both known inhibitors
of PLA2 (Kunze et al., 1976). It was thus of interest to also
determine whether tacrine would affect the activity of this
enzyme. Ethanol-injected PPHPG vesicles were used as a
substrate, and PLA2-catalyzed phospholipid hydrolysis was
measured by monitoring the liberation of pyrene-labeled
fatty acid. However, at least under these conditions the
presence of tacrine (up to 1: 1 drug:lipid molar ratio) had no
effect whatsoever on phospholipase A2 activity (data not
shown).
DISCUSSION
The chemical structure of tacrine, a drug used in the treat-
ment of the symptoms of Alzheimer's disease, readily sug-
gests that this compound binds to lipids. Accordingly, we
investigated this possibility by fluorescence polarization, by
measuring restriction of its motion upon binding to lipo-
somes, by the monolayer technique, as well as by quanti-
tating drug-induced changes in the thermal phase behavior
of DMPA by differential scanning calorimetry. Strong as-
sociation of this drug to acidic phospholipid-containing
membranes could be demonstrated, whereas little selectivity
between different monovalent acidic lipids was evident. The
concentration of membrane-bound tacrine increased mono-
tonically as a function of increasing acidic phospholipid:
tacrine molar ratios, as revealed by fluorescence polariza-
tion. Instead, tacrine did not bind to vesicles formed from
zwitterionic lipids, such as PC. Notably, upon mixing of
increasing amounts of PE into PC matrix, no binding of
tacrine could be seen, suggesting that the hydration layer of
PC does not provide an energy barrier preventing tacrine
penetration into the bilayer. Tacrine is an amphipathic mol-
ecule, and it is thus expected to reside in the interfacial
region of the bilayer. For DOPC, for instance, this zone has
been estimated to account for -50% of the total thermal
thickness of the membrane (White and Whimley, 1994).
However, the lack of interaction with zwitterionic phospho-
lipids also reveals that hydrophobicity alone is not sufficient
for the membrane binding of tacrine. Evidence for an elec-
trostatic interaction with acidic phospholipids is provided
by the enhanced binding of tacrine to DOPC vesicles upon
increasing their egg PG content. Likewise, increasing the
ionic strength of [NaCl] dissociates, although incompletely,
tacrine from the acidic egg PG, thus suggesting two differ-
ent types of tacrine-binding sites in the membrane, as is the
case for adriamycin. In keeping with electrostatic forces
being important, charge neutralization of egg PG in the
plane of the membrane by the positively charged amphi-
phile sphingosine completely reverses the membrane asso-
ciation of tacrine. The penetration of tacrine into egg PG
monolayers is in accordance with the location of the drug in
the interface. Notably, the glycerophosiholipid structure is
inessential for the electrostatic association of tacrine to
Lehtonen et al. 2191
Volume 70 May 1996
liposomes, and efficient binding is also observed with
DOPC membranes containing cholesteryl sulphate.
Interestingly, the binding of tacrine to DMPA is temper-
ature dependent and is significantly reduced below Tm. This
can be understood to result from the increased lateral pack-
ing of DMPA in the gel state. Diminished penetration into
lipid monolayers has been shown for a number of com-
pounds (e.g., adriamycin) at increasing lipid packing den-
sities (Mustonen and Kinnunen, 1991). In contrast to
DMPA, tacrine binds to DMPG equally effectively, both
below and above Tm, thus suggesting that below Tm the
association of tacrine with membranes also has specificity
with respect to the polar headgroup structure. This differ-
ence might be due to the different orientation of the head-
group phosphate moieties of PG and PA. On the other hand,
effective and tight hydrogen-bonded networks have been
suggested to be formed by PA (Eibl and Woolley, 1979),
whereas similar tight association of the headgroups due to
hydrogen bonding should not be possible for PG. Such
hydrogen bonding should be augmented below Tm of
DMPA and result in diminished membrane association of
tacrine, whereas binding to DMPG would not be similarly
affected by the transition.
Binding of tacrine (drug:lipid stoichiometry < 1:2) to
membrane decreased both Tm and AH, thus indicating
weakened intermolecular interactions between DMPA mol-
ecules. However, membranes of different tacrine-DMPA
stoichiometries exhibit strongly nonlinear thermal behavior
as a function of the content of drug. More specifically, at
critical drug:lipid molar ratios, structures with either higher
or lower melting enthalpies are formed. Likewise, stepwise
decrements in Tm were evident at well-defined tacrine:
DMPA stoichiometries. As far as we know irregular thermal
phase behavior such as that reported here for tacrine:DMPA
complexes has not been observed previously for drug-lipid
interactions.
The appearance of the shoulder on the high temperature
side of the main transition is indicative of phase separation.
The shoulder becomes more pronounced at tacrine concen-
trations exceeding 19 mol%, and its enthalpy increases upon
increasing tacrine concentration, so as to constitute a max-
imum of approximately 16% of the total transition enthalpy
AH. Accordingly, it cannot explain the irregular variation in
AlH seen as a function of tacrine concentration.
The relationship between a global thermodynamic quan-
tity such as heat capacity and phase diagrams and mem-
brane microstructure is not trivial. The observed changes in
Tm and total enthalpy content of the endotherms upon vary-
ing the drug:lipid stoichiometry relate to the "melting" of
the lattices formed. The fact that these changes take place
abruptly at fairly well-defined drug:lipid molar ratios could
indicate the presence of structured drug:lipid alloys, the
actual organization being dependent on the relative propor-
tions of the constituents. Yet, the DSC data do not give any
insight into the actual structures formed. Notably, a high
degree of ordering in binary membranes would not be
Evidence for the formation of superstructures in liquid
crystalline cardiolipin/phosphatidylcholine membranes was
reported by Berclaz and McConnell (Berclaz and McCon-
nell, 1981; Berclaz and Geoffrey, 1984). Membrane partial
specific volumes as well as lipid lateral diffusion rates are
altered in a strongly nonlinear manner by varying choles-
terol:phospholipid stoichiometry (Rubenstein et al., 1979,
1980; Recktenwald and McConnell, 1981; Carruthers and
Melchior, 1986). To this end, regular distribution of sterols
in liquid crystalline phosphatidylcholine vesicles has re-
cently been demonstrated (Chong, 1994; Tang et al., 1995).
Our laboratory provided evidence for the regular distribu-
tion of the pyrene-labeled phospholipid analog PPDPC in
binary liquid crystalline lipid mixtures and Langmuir-
Blodgett films (Somerharju et al., 1985; Kinnunen et al.,
1987). Likewise, dips in the pyrene excimer-to-monomer
fluorescence emission intensity ratio observed for DMPC
liposomes containing increasing amounts of PPDPC (Tang
and Chong, 1992; Chong et al., 1994) were interpreted to
result from concentration-dependent organization of
pyrene-labeled acyl chains into hexagonal superlattices at
critical mole fractions (Kinnunen et al., 1987; Virtanen et
al., 1988; Sugar et al., 1994). Regular distribution is be-
lieved to arise from the long-range repulsive interaction
between PPDPC molecules due to elastic deformation of the
lipid matrix around the bulky pyrene moiety acting as a
substitutional impurity (Kinnunen et al., 1993). The exis-
tence of regular patterns is determined by the balance be-
tween the energy minimization due to maximum separation
of the impurities and their entropy-driven randomization.
Somewhat analogously to the above, we interpreted our
resonance energy transfer measurements on the membrane
association of cytochrome c in terms of the formation of
hexagonal arrays of protein on liposome surfaces (Mus-
tonen et al., 1987).
As is the case for pyrene- and cholesterol-induced per-
turbation of lipid packing in phosphatidylcholine liposomes,
the binding of tacrine to the DMPA polar headgroup and its
partial penetration into the bilayer should cause both steric
perturbation as well as disruption of the hydrogen-bonded
network of DMPA. Accordingly, the different alloys formed
at the different drug:lipid stoichiometries by tacrine and
DMPA (the former residing in the interface) should each
posses different melting temperatures and enthalpies. How-
ever, at this stage of our studies the above should be
considered as a working hypothesis only, and further data
are clearly warranted to substantiate this possibility. Nota-
bly, phase separation and possible formation of structured
alloys due to membrane-associated drug are not mutually
exclusive.
The preferential association of tacrine with acidic phos-
pholipids demonstrated in the present study opens novel
possibilities of elucidating its therapeutic mechanism of
action. Unfortunately, although drug-lipid interactions are
abundant, their importance has remained open. Yet, the in
vitro evidence accumulated on membranes and drug-mem-
without precedent.
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membrane binding could mediate a wide range of effects.
For instance, for pathophysiological processes such as mul-
tidrug resistance of cancer cells, a role for drug-lipid inter-
actions has been suggested (Escriba et al., 1990; Canaves et
al., 1991; Callaghan et al., 1993; Wadkins and Houghton,
1993). Likewise, the mechanism of action of adriamycin has
been related to its lipid interactions, as it is cytotoxic with-
out entering the cell (Tritton and Yee, 1982). This effect
could be explained by the activation of phospholipases A2
by adriamycin (Mustonen and Kinnunen, 1991). Mobility of
lipids in membranes is important for the function of several
membrane-associated enzymes and has been shown to be
altered by a number of drugs (Siegfried et al., 1983; Wright
and White, 1986). Likewise, thickness of the membrane has
emerged as an important parameter modulating the structure
and function of several integral membrane proteins (Cornea
and Thomas, 1994). To this end, it is of interest that high
concentrations of chlorpromazine have been demonstrated
to increase the thickness of erythrocyte membranes (Lieber
et al., 1984). Membrane might serve also as a concentrator,
facilitating the binding of drugs and peptide hormones to
their receptors (Rhodes et al., 1985; Herbette et al., 1986;
Sargent and Schwyzer, 1986).
Binding of drugs to phospholipids could also modulate
the membrane interactions of peripheral proteins, as shown
for chlorpromazine, which prevents the membrane associa-
tion of vinculin (Ito et al., 1983). The pathophysiology of
Alzheimer's disease and its progression centrally involves
amyloid formation, resulting from the accumulation of a
hydrophobic peptide AP3 of a known amino acid sequence
(Marotta et al., 1992). Strong enhancement of the aggrega-
tion of this peptide by acidic phospholipids has recently
been observed (Terzi et al., 1994). Accordingly, binding of
tacrine to acidic phospholipids might interfere with the
interaction of A,B-peptide with negatively charged phospho-
lipids. This possibility is currently being investigated in our
laboratory.
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